AEON Biopharma Financial Overview
AEON Biopharma's market cap is currently $12.79M. The company's EPS TTM is $-0.39; its P/E ratio is 0.21; AEON Biopharma is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
